Successful treatment of a lung adenocarcinoma patient with a novel EGFR exon 20-ins mutation with afatinib
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
General Medicine
Reference28 articles.
1. Clinical and biological features associated with epidermal growth factor receptor gene mutation in lung cancers;Shigematsu;J Natl Cancer Inst,2005
2. Rare EGFR exon 18 and exon 20 mutation in non-small-cell lung cancer on 10 117 patients: a multicentre observational study by the French ERMETIC-IFCT network;Beau-Faller;Ann Oncol,2014
3. In vitro modeling to determine mutation specificity of EGFR tyrosine kinase inhibitors against clinically relevant EGFR mutants in non-small-cell lung cancer;Hirano;Oncotarget,2015
4. EGFR exon 20 insertion mutation in non-small-cell lung cancer: preclinical data and clinical implications;Yasuda;Lancet Oncol,2012
5. EGFR exon 20 insertion mutation in lung adenocarcinomas: prevalence, molecular heterogeneity, and clinicopathologic characteristics;Arcila;Mol Cancer Ther,2013
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Characteristics, treatment patterns, and clinical outcomes in patients with advanced non-small cell lung cancer harboring EGFR exon 20 insertions;Journal of Cancer Research and Clinical Oncology;2023-06-05
2. Afatinib for the Treatment of NSCLC with Uncommon EGFR Mutations: A Narrative Review;Current Oncology;2023-05-28
3. Structural dynamics and kinase inhibitory activity of three generations of tyrosine kinase inhibitors against wild-type, L858R/T790M, and L858R/T790M/C797S forms of EGFR;Computers in Biology and Medicine;2022-08
4. Tyrosine Kinase Inhibitor Activity in Patients with NSCLC Harboring Uncommon EGFR Mutations: A Retrospective International Cohort Study (UpSwinG);The Oncologist;2022-03-11
5. Real-world experience of afatinib as first-line therapy for advanced EGFR mutation-positive non-small cell lung cancer in Korea;Translational Lung Cancer Research;2021-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3